The uptake of blocking anti-IL-17 antibody was reported to antagonize the Ab1 − 42 injected into the cerebral ventricles of CD1 mice and ameliorate cognitive impairment and neuroinflammation (Cristiano et al. 2019). Here, IL17A is linked to Cognitive impairment.